Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam P Dicker

Showing results (271-280 of 286) with videos related to

Pageof 29
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2025
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck CancerMitchell Machtay, Pedro A Torres-Saavedra, Wade Thorstad, et al.
Neuroradiology|July 19, 2023
Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortiumMatthew D Lee, Sohil H Patel, Suyash Mohan, et al.
Journal of the National Cancer Institute|September 2, 2022
Genomic Testing in Localized Prostate Cancer Can Identify Subsets of African Americans With Aggressive DiseaseShivanshu Awasthi, G Daniel Grass, Javier Torres-Roca, et al.
JAMA Oncology|February 11, 2021
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical TrialFelix Y Feng, Huei-Chung Huang, Daniel E Spratt, et al.
Neuro-Oncology|March 11, 2020
AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortiumChristos Davatzikos, Jill S Barnholtz-Sloan, Spyridon Bakas, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
A Prospective Validation of the Decipher Genomic Classifier in Men With Early Localized Prostate Cancer: The VANDAAM StudyKosj Yamoah, Purvish Trivedi, Shivanshu Awasthi, et al.
Neuro-Oncology|May 17, 2026
Modern Molecular Profiling Recontextualizes the NRG/RTOG 0539 Trial and Reveals Hidden High-Risk and Radiotherapy Resistant MeningiomasLeeor S Yefet, Alexander P Landry, C Leland Rogers, et al.
JCO Precision Oncology|March 21, 2024
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung CancerPetros Christopoulos, Michal Harel, Kimberly McGregor, et al.
EMBO Molecular Medicine|November 24, 2018
PARP-1 regulates DNA repair factor availabilityMatthew J Schiewer, Amy C Mandigo, Nicolas Gordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2017
Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate CancerDaniel E Spratt, Jingbin Zhang, María Santiago-Jiménez, et al.
Pageof 29

Showing results (271-280 of 286) with videos related to

Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2025
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck CancerMitchell Machtay, Pedro A Torres-Saavedra, Wade Thorstad, et al.
Neuroradiology|July 19, 2023
Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortiumMatthew D Lee, Sohil H Patel, Suyash Mohan, et al.
Journal of the National Cancer Institute|September 2, 2022
Genomic Testing in Localized Prostate Cancer Can Identify Subsets of African Americans With Aggressive DiseaseShivanshu Awasthi, G Daniel Grass, Javier Torres-Roca, et al.
JAMA Oncology|February 11, 2021
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical TrialFelix Y Feng, Huei-Chung Huang, Daniel E Spratt, et al.
Neuro-Oncology|March 11, 2020
AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortiumChristos Davatzikos, Jill S Barnholtz-Sloan, Spyridon Bakas, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
A Prospective Validation of the Decipher Genomic Classifier in Men With Early Localized Prostate Cancer: The VANDAAM StudyKosj Yamoah, Purvish Trivedi, Shivanshu Awasthi, et al.
Neuro-Oncology|May 17, 2026
Modern Molecular Profiling Recontextualizes the NRG/RTOG 0539 Trial and Reveals Hidden High-Risk and Radiotherapy Resistant MeningiomasLeeor S Yefet, Alexander P Landry, C Leland Rogers, et al.
JCO Precision Oncology|March 21, 2024
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung CancerPetros Christopoulos, Michal Harel, Kimberly McGregor, et al.
EMBO Molecular Medicine|November 24, 2018
PARP-1 regulates DNA repair factor availabilityMatthew J Schiewer, Amy C Mandigo, Nicolas Gordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2017
Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate CancerDaniel E Spratt, Jingbin Zhang, María Santiago-Jiménez, et al.
Pageof 29